305 related articles for article (PubMed ID: 29532101)
1. Diagnostic performance and impact on patient management of
Paquet M; Gauthé M; Zhang Yin J; Nataf V; Bélissant O; Orcel P; Roux C; Talbot JN; Montravers F
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1710-1720. PubMed ID: 29532101
[TBL] [Abstract][Full Text] [Related]
2. [Value of
Zhang S; Wang L; Wang T; Xing HQ; Huo L; Li F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):757-764. PubMed ID: 30606385
[TBL] [Abstract][Full Text] [Related]
3. 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.
Breer S; Brunkhorst T; Beil FT; Peldschus K; Heiland M; Klutmann S; Barvencik F; Zustin J; Gratz KF; Amling M
Bone; 2014 Jul; 64():222-7. PubMed ID: 24769333
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
Morgat C; Vélayoudom-Céphise FL; Schwartz P; Guyot M; Gaye D; Vimont D; Schulz J; Mazère J; Nunes ML; Smith D; Hindié E; Fernandez P; Tabarin A
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1258-66. PubMed ID: 26819103
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of
Kato A; Nakamoto Y; Ishimori T; Hayakawa N; Ueda M; Temma T; Sano K; Shimizu Y; Saga T; Togashi K
Ann Nucl Med; 2021 Mar; 35(3):397-405. PubMed ID: 33582980
[TBL] [Abstract][Full Text] [Related]
6. Comparison of
Yu HN; Liu L; Chen QS; He Q; Li YS; Wang Y; Gao S
Orthop Surg; 2021 May; 13(3):791-798. PubMed ID: 33709632
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic efficiency of
He Q; Zhang B; Zhang L; Chen Z; Shi X; Yi C; Wang X; Zhang X
Eur Radiol; 2021 Apr; 31(4):2414-2421. PubMed ID: 33021702
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of
Li B; Duan L; Li X; Shi J; Li H; Liu H; Cheng X; Wu X; Gao Y
Front Oncol; 2023; 13():1228575. PubMed ID: 37554164
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of (68)Ga-DOTA-TOC and (18)F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle.
Nilica B; Waitz D; Stevanovic V; Uprimny C; Kendler D; Buxbaum S; Warwitz B; Gerardo L; Henninger B; Virgolini I; Rodrigues M
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1585-92. PubMed ID: 26922350
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of Ga-68 DOTA-SSTR and F-18 FDG PET/CT in the detection of culprit tumours causing osteomalacia: a systematic review and meta-analysis.
Agrawal K; Padhy BM; Meher BR; Mohanty RR
Nucl Med Commun; 2021 Jun; 42(6):646-655. PubMed ID: 33625187
[TBL] [Abstract][Full Text] [Related]
11. 68Ga DOTATATE PET/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia.
Zhang J; Zhu Z; Zhong D; Dang Y; Xing H; Du Y; Jing H; Qiao Z; Xing X; Zhuang H; Li F
Clin Nucl Med; 2015 Aug; 40(8):642-6. PubMed ID: 26053726
[TBL] [Abstract][Full Text] [Related]
12. Performance of 68Ga-DOTA-SST PET/CT, octreoscan SPECT/CT and 18F-FDG PET/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis.
Jiang Y; Hou G; Cheng W
Nucl Med Commun; 2020 Apr; 41(4):370-376. PubMed ID: 32000173
[TBL] [Abstract][Full Text] [Related]
13.
El-Maouche D; Sadowski SM; Papadakis GZ; Guthrie L; Cottle-Delisle C; Merkel R; Millo C; Chen CC; Kebebew E; Collins MT
J Clin Endocrinol Metab; 2016 Oct; 101(10):3575-3581. PubMed ID: 27533306
[TBL] [Abstract][Full Text] [Related]
14.
Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Url C; Riechelmann H; Sprinzl GM; Thomé C; Treglia G; Kjaer A; Fraedrich G; Virgolini IJ
Nucl Med Biol; 2019 Apr; 71():47-53. PubMed ID: 31152973
[TBL] [Abstract][Full Text] [Related]
15. Utility of Gallium-68 DOTANOC PET/CT in the localization of Tumour-induced osteomalacia.
Bhavani N; Reena Asirvatham A; Kallur K; Menon AS; Pavithran PV; Nair V; Vasukutty JR; Menon U; Kumar H
Clin Endocrinol (Oxf); 2016 Jan; 84(1):134-40. PubMed ID: 25996566
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of 68Ga-DOTA-TATE PET/CT imaging for tumor- induced osteomalacia.
Zhang Y; Zhang X; Zhang W; Huang Z; Chen Y
Ann Palliat Med; 2020 Sep; 9(5):3350-3356. PubMed ID: 32921125
[TBL] [Abstract][Full Text] [Related]
17. Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET/CT vs somatostatin receptor-based functional scans: a series of nine patients.
Jadhav S; Kasaliwal R; Lele V; Rangarajan V; Chandra P; Shah H; Malhotra G; Jagtap VS; Budyal S; Lila AR; Bandgar T; Shah NS
Clin Endocrinol (Oxf); 2014 Jul; 81(1):31-7. PubMed ID: 24528172
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance and impact on patient management of [68Ga]Ga-DOTA-TOC PET/CT in colorectal neuroendocrine tumors derived from hindgut.
Delabie P; Baudin É; Hentic O; Afchain P; Rusu T; Montravers F
Medicine (Baltimore); 2022 Nov; 101(47):e31512. PubMed ID: 36451394
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.
Singh D; Chopra A; Ravina M; Kongara S; Bhatia E; Kumar N; Gupta S; Yadav S; Dabadghao P; Yadav R; Dube V; Kumar U; Dixit M; Gambhir S
Br J Radiol; 2017 Apr; 90(1072):20160811. PubMed ID: 28181822
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.
Agrawal K; Bhadada S; Mittal BR; Shukla J; Sood A; Bhattacharya A; Bhansali A
Clin Nucl Med; 2015 Jan; 40(1):e6-e10. PubMed ID: 24999675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
